CD34 and acute myeloid leukemia: We evaluated the effect of DS-1594a·succinate on induction of differentiation and loss of CD34 + /CD38 − cells, which are a fraction of potential LICs, in patient-derived MLL1-r + AML cells (AML#8531, AML676, and NCCHD010) in vitro.